Skip links and keyboard navigation

Department of Environment and Science

Queensland Government

Science portfolio of the Department of Environment and Science

Department of Environment and Science

Queensland science capability directory

Back to directory

Diamantina Institute (UQDI)

People moving at the Diamantina Institute

The University of Queensland

The Diamantina Institute has a particular focus on severe and chronic diseases such as cancer, and diseases involving the immune system, including arthritis, chronic infections and diabetes. We are dedicated to improving the management of these conditions through biomedical research into their causes, and we place particular emphasis on translation of that research into new therapies and diagnostic methods that make a difference to wellbeing. We are proud to be a leading institute of The University of Queensland, and support its missions of learning, discovery and engagement through: training of the next generation of scientists and clinician scientists; partnering with the community, and collaborations with researchers worldwide who share our aims and research focus.


Key science sectors

Strengths and capabilities

  • Cancer research
  • Immunology
  • Genomic Medicine

Facilities and major equipment

  • Access to facilities of the Translational Research Institute

Number of research staff

200–300 research staff


Diamantina Institute, Translational Research Institute, 37 Kent Street, Woolloongabba, 4102

Lead researchers

  • Professor Ranjeny Thomas—Has developed a diagnostic test for juvenile diabetes and founded UniQuest’s Dendright that is developing a rheumatoid arthritis vaccine.
  • Professor Maher Gandhi—Has an international reputation for his work on immunity and identification of novel biomarkers in lymphoma.
  • Professor David Evans—Led the genetic studies of the Avon Longitudinal Study of Parents and Children. Now leads work on understanding genomic causes of diseases.

Achievements of the centre

  • Discovery, development and release of the world’s first cervical cancer vaccine
  • Early clinical trial success for a new vaccine-style therapeutic approach to treat rheumatoid arthritis
  • Development of a test that will direct treatment choices for patients with a specific form of non-Hodgkin’s lymphoma

Organisation type

  • University Research Centre

Help us improve this directory by taking a short survey. Take the survey (new window)

Register your centre

Register your centre to be listed in this directory.

Last updated:
6 September 2018